As is as important is all taxpayers of Australia as biotech R&D in these early stages is funded by the substantial R&D cash rebate that they get for qualified expenditures. Would hate to see CYP taken out by an overseas entity at this substantially discounted value IMO!
Ann: March 2025 Quarterly Activity Report and Appendix 4C, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $39.54M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $6.287K | 35.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 67866 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 42766 | 4 |
View Market Depth
| Last trade - 11.42am 29/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |